Two American Ebola patients given experimental therapy | Science News

Real Science. Real News.

Science News is a nonprofit.

Support us by subscribing now.

Science Ticker

A roundup of research
and breaking news

Science News Staff
Science Ticker

Two American Ebola patients given experimental therapy

Sponsor Message

Guest post by Lila Guterman

According to news reports, the two American missionaries infected with the Ebola virus in Liberia have been treated with an experimental therapy that consists of antibodies to fragments of the deadly virus. CNN and the Washington Post report that the health of the two patients, Kent Brantly and Nancy Writebol, has improved since they received treatment. As of Tuesday, both patients had been transported from Africa to Emory University Hospital in Atlanta.

The antibody therapy, made by a San Francisco-based biotechnology company called Mapp Biopharmaceutical, had previously only been tested in animals. Other experimental drugs and vaccines are in various stages of testing, including a dual therapy of antibodies and the antiviral drug interferon alpha, which showed promise in monkey tests last year.

See all of SN’s Ebola coverage.

Get Science News headlines by e-mail.

More on Ebola

From the Nature Index Paid Content